Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorodeoxyglucose F18 | 65 | 2024 | 2016 | 8.630 |
Why?
|
Arteritis | 22 | 2024 | 159 | 8.610 |
Why?
|
Positron-Emission Tomography | 71 | 2023 | 6234 | 4.780 |
Why?
|
Radiopharmaceuticals | 47 | 2023 | 2645 | 4.590 |
Why?
|
Atherosclerosis | 44 | 2024 | 3445 | 4.400 |
Why?
|
Plaque, Atherosclerotic | 24 | 2023 | 1519 | 3.140 |
Why?
|
Noise, Transportation | 3 | 2022 | 50 | 2.280 |
Why?
|
Amygdala | 8 | 2023 | 1315 | 2.170 |
Why?
|
Molecular Imaging | 7 | 2022 | 828 | 1.960 |
Why?
|
Inflammation | 35 | 2024 | 10638 | 1.940 |
Why?
|
Aorta, Thoracic | 8 | 2021 | 1082 | 1.810 |
Why?
|
Aortitis | 6 | 2020 | 74 | 1.790 |
Why?
|
Cardiovascular Diseases | 19 | 2024 | 15165 | 1.730 |
Why?
|
Carotid Artery Diseases | 10 | 2016 | 882 | 1.620 |
Why?
|
Coronary Artery Disease | 24 | 2023 | 6487 | 1.600 |
Why?
|
Cardiovascular System | 3 | 2024 | 832 | 1.410 |
Why?
|
Editorial Policies | 2 | 2023 | 451 | 1.320 |
Why?
|
Stress, Psychological | 7 | 2023 | 4245 | 1.260 |
Why?
|
Heptanoic Acids | 3 | 2014 | 343 | 1.200 |
Why?
|
Pyrroles | 4 | 2015 | 1146 | 1.200 |
Why?
|
Periodontal Diseases | 3 | 2019 | 449 | 1.190 |
Why?
|
Carotid Stenosis | 6 | 2016 | 854 | 1.160 |
Why?
|
Coronary Vessels | 10 | 2023 | 3107 | 1.140 |
Why?
|
Anti-Inflammatory Agents | 10 | 2023 | 1790 | 1.120 |
Why?
|
Tomography, X-Ray Computed | 33 | 2023 | 20129 | 1.100 |
Why?
|
Publishing | 2 | 2023 | 833 | 1.100 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 591 | 1.030 |
Why?
|
Bone Marrow | 6 | 2021 | 2948 | 1.020 |
Why?
|
HIV Infections | 15 | 2024 | 16718 | 1.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2022 | 3255 | 1.000 |
Why?
|
Predictive Value of Tests | 31 | 2023 | 15076 | 0.940 |
Why?
|
Carotid Arteries | 6 | 2021 | 952 | 0.920 |
Why?
|
Social Class | 3 | 2022 | 1999 | 0.890 |
Why?
|
Aorta | 8 | 2021 | 2061 | 0.880 |
Why?
|
Arthritis, Rheumatoid | 5 | 2024 | 3712 | 0.870 |
Why?
|
Arteries | 5 | 2019 | 1119 | 0.850 |
Why?
|
Coronary Circulation | 7 | 2007 | 1572 | 0.830 |
Why?
|
Hematopoiesis | 5 | 2019 | 2072 | 0.810 |
Why?
|
Takayasu Arteritis | 1 | 2023 | 96 | 0.800 |
Why?
|
Heart | 9 | 2024 | 4467 | 0.770 |
Why?
|
Sodium Fluoride | 2 | 2021 | 65 | 0.770 |
Why?
|
Aortography | 5 | 2020 | 437 | 0.750 |
Why?
|
Aortic Diseases | 4 | 2015 | 742 | 0.750 |
Why?
|
Spleen | 4 | 2021 | 2362 | 0.720 |
Why?
|
Lighting | 1 | 2022 | 231 | 0.710 |
Why?
|
Adiposity | 3 | 2019 | 1807 | 0.690 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 125 | 0.680 |
Why?
|
Humans | 151 | 2024 | 744343 | 0.680 |
Why?
|
Macrophages | 8 | 2018 | 5655 | 0.680 |
Why?
|
Calcinosis | 2 | 2021 | 1499 | 0.680 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 292 | 0.660 |
Why?
|
Fluorides | 1 | 2019 | 127 | 0.650 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2023 | 554 | 0.620 |
Why?
|
Air Pollutants | 2 | 2022 | 2817 | 0.610 |
Why?
|
Vasculitis | 6 | 2020 | 519 | 0.570 |
Why?
|
Edema, Cardiac | 1 | 2016 | 18 | 0.560 |
Why?
|
Middle Aged | 74 | 2024 | 213383 | 0.560 |
Why?
|
Male | 93 | 2024 | 350118 | 0.560 |
Why?
|
Risk Factors | 35 | 2024 | 72290 | 0.550 |
Why?
|
Lymphadenitis | 1 | 2017 | 98 | 0.550 |
Why?
|
Obesity, Abdominal | 1 | 2019 | 361 | 0.540 |
Why?
|
Venous Thrombosis | 4 | 2021 | 1239 | 0.530 |
Why?
|
Phosphofructokinase-2 | 1 | 2015 | 32 | 0.520 |
Why?
|
Fluorine Radioisotopes | 4 | 2022 | 442 | 0.520 |
Why?
|
Stroke | 6 | 2023 | 9981 | 0.510 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 461 | 0.510 |
Why?
|
Vasodilation | 4 | 2005 | 944 | 0.500 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 697 | 0.490 |
Why?
|
C-Reactive Protein | 5 | 2024 | 3778 | 0.490 |
Why?
|
Contrast Media | 7 | 2016 | 5300 | 0.490 |
Why?
|
Environment | 1 | 2020 | 1124 | 0.480 |
Why?
|
Brain Ischemia | 3 | 2023 | 3265 | 0.480 |
Why?
|
Coronary Angiography | 12 | 2023 | 4577 | 0.470 |
Why?
|
Female | 84 | 2024 | 380194 | 0.470 |
Why?
|
Pericardial Effusion | 1 | 2016 | 247 | 0.470 |
Why?
|
Aged | 50 | 2024 | 163280 | 0.460 |
Why?
|
Adipose Tissue, Brown | 3 | 2016 | 757 | 0.450 |
Why?
|
Rubidium Radioisotopes | 1 | 2013 | 85 | 0.450 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2013 | 127 | 0.440 |
Why?
|
Environmental Pollutants | 1 | 2022 | 1179 | 0.440 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.440 |
Why?
|
Interleukin-1beta | 1 | 2018 | 972 | 0.440 |
Why?
|
Triazines | 1 | 2015 | 315 | 0.440 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 88 | 0.440 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 903 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 13 | 2022 | 35421 | 0.430 |
Why?
|
Vasodilator Agents | 4 | 2005 | 977 | 0.420 |
Why?
|
Double-Blind Method | 18 | 2019 | 12026 | 0.410 |
Why?
|
Synovial Membrane | 1 | 2014 | 507 | 0.400 |
Why?
|
Rabbits | 9 | 2021 | 4894 | 0.400 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 640 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11725 | 0.390 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.390 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1224 | 0.380 |
Why?
|
Myocarditis | 2 | 2016 | 771 | 0.380 |
Why?
|
CD4 Lymphocyte Count | 6 | 2021 | 2559 | 0.370 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2021 | 8949 | 0.370 |
Why?
|
Aortic Valve Stenosis | 2 | 2014 | 1965 | 0.370 |
Why?
|
Risk Assessment | 14 | 2022 | 23338 | 0.370 |
Why?
|
Sulfonylurea Compounds | 1 | 2011 | 204 | 0.360 |
Why?
|
DNA, Viral | 1 | 2017 | 2225 | 0.360 |
Why?
|
Radionuclide Imaging | 4 | 2023 | 2031 | 0.360 |
Why?
|
Angina Pectoris | 2 | 2013 | 977 | 0.350 |
Why?
|
Longitudinal Studies | 8 | 2020 | 13989 | 0.350 |
Why?
|
HIV | 1 | 2017 | 1604 | 0.340 |
Why?
|
Sulfhydryl Compounds | 5 | 2016 | 298 | 0.340 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 119 | 0.340 |
Why?
|
Tomography, Optical | 1 | 2010 | 126 | 0.340 |
Why?
|
Infarction | 2 | 2022 | 244 | 0.330 |
Why?
|
Thiazolidinediones | 1 | 2011 | 476 | 0.320 |
Why?
|
Myocardial Ischemia | 4 | 2013 | 2148 | 0.310 |
Why?
|
Psoriasis | 3 | 2021 | 898 | 0.310 |
Why?
|
Inflammation Mediators | 5 | 2019 | 1889 | 0.310 |
Why?
|
Receptors, Scavenger | 1 | 2007 | 121 | 0.300 |
Why?
|
Lipids | 2 | 2018 | 3305 | 0.300 |
Why?
|
Glucose Intolerance | 1 | 2011 | 577 | 0.300 |
Why?
|
Air Pollution | 1 | 2021 | 2286 | 0.300 |
Why?
|
Adult | 37 | 2021 | 214055 | 0.290 |
Why?
|
Ethanol | 2 | 2023 | 1342 | 0.290 |
Why?
|
Acute Coronary Syndrome | 4 | 2015 | 2337 | 0.280 |
Why?
|
Ultrasonography, Doppler | 3 | 2018 | 458 | 0.280 |
Why?
|
Retrospective Studies | 18 | 2023 | 77449 | 0.280 |
Why?
|
Veins | 2 | 2021 | 770 | 0.280 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7785 | 0.280 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 9274 | 0.280 |
Why?
|
Whole Body Imaging | 2 | 2020 | 280 | 0.280 |
Why?
|
Brachial Artery | 2 | 2018 | 369 | 0.280 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 818 | 0.280 |
Why?
|
Photosensitizing Agents | 2 | 2007 | 602 | 0.280 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4266 | 0.280 |
Why?
|
Time Factors | 15 | 2020 | 40075 | 0.280 |
Why?
|
Heart Diseases | 1 | 2019 | 2788 | 0.270 |
Why?
|
Sensitivity and Specificity | 10 | 2017 | 14722 | 0.270 |
Why?
|
Magnetic Resonance Angiography | 2 | 2016 | 1442 | 0.270 |
Why?
|
Neutrophils | 2 | 2015 | 3719 | 0.270 |
Why?
|
Arteriosclerosis | 3 | 2006 | 1092 | 0.260 |
Why?
|
Angina, Unstable | 1 | 2010 | 926 | 0.260 |
Why?
|
Serum Albumin, Bovine | 1 | 2006 | 324 | 0.260 |
Why?
|
Lymph Nodes | 1 | 2017 | 3474 | 0.260 |
Why?
|
Reproducibility of Results | 8 | 2017 | 19905 | 0.260 |
Why?
|
Aortic Valve | 1 | 2014 | 1922 | 0.250 |
Why?
|
Methotrexate | 3 | 2022 | 1727 | 0.240 |
Why?
|
Thrombosis | 2 | 2015 | 2968 | 0.240 |
Why?
|
Prognosis | 9 | 2023 | 29063 | 0.240 |
Why?
|
Prospective Studies | 15 | 2023 | 53288 | 0.240 |
Why?
|
Myocardium | 4 | 2018 | 4776 | 0.240 |
Why?
|
Phospholipids | 2 | 2020 | 784 | 0.240 |
Why?
|
Porphyrins | 1 | 2006 | 348 | 0.230 |
Why?
|
Angioscopy | 1 | 2003 | 49 | 0.230 |
Why?
|
MERRF Syndrome | 1 | 2003 | 4 | 0.230 |
Why?
|
Blood Component Removal | 2 | 2014 | 125 | 0.230 |
Why?
|
Regional Blood Flow | 2 | 2005 | 1525 | 0.230 |
Why?
|
Image Enhancement | 2 | 2016 | 2921 | 0.230 |
Why?
|
Disease Progression | 8 | 2021 | 13284 | 0.220 |
Why?
|
Mitochondrial Myopathies | 1 | 2003 | 47 | 0.220 |
Why?
|
Central Nervous System Depressants | 1 | 2004 | 167 | 0.220 |
Why?
|
Heart Transplantation | 1 | 2016 | 3110 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3327 | 0.220 |
Why?
|
Epilepsies, Myoclonic | 1 | 2003 | 80 | 0.210 |
Why?
|
Environmental Exposure | 3 | 2022 | 4234 | 0.210 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2699 | 0.210 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.210 |
Why?
|
Receptors, Somatostatin | 1 | 2023 | 129 | 0.210 |
Why?
|
Treatment Outcome | 21 | 2024 | 63114 | 0.210 |
Why?
|
Tissue Distribution | 4 | 2016 | 2327 | 0.210 |
Why?
|
Hyperhomocysteinemia | 1 | 2002 | 124 | 0.210 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2022 | 53 | 0.210 |
Why?
|
Coronary Artery Bypass | 2 | 2022 | 2289 | 0.200 |
Why?
|
Income | 2 | 2021 | 1913 | 0.200 |
Why?
|
Acidosis, Lactic | 1 | 2003 | 142 | 0.200 |
Why?
|
Glycolysis | 2 | 2016 | 827 | 0.200 |
Why?
|
Chest Pain | 3 | 2022 | 1114 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5535 | 0.200 |
Why?
|
Adenosine | 2 | 2005 | 825 | 0.200 |
Why?
|
Recombinant Proteins | 3 | 2016 | 6622 | 0.190 |
Why?
|
Periodontium | 1 | 2021 | 99 | 0.190 |
Why?
|
Leukopoiesis | 1 | 2020 | 56 | 0.190 |
Why?
|
Intracranial Thrombosis | 1 | 2021 | 113 | 0.190 |
Why?
|
Case-Control Studies | 11 | 2020 | 21746 | 0.190 |
Why?
|
Aorta, Abdominal | 2 | 2021 | 646 | 0.190 |
Why?
|
Boston | 5 | 2016 | 9313 | 0.180 |
Why?
|
Neurobiology | 1 | 2021 | 121 | 0.180 |
Why?
|
Particulate Matter | 2 | 2022 | 2530 | 0.180 |
Why?
|
Animals | 23 | 2021 | 168757 | 0.180 |
Why?
|
Blood Circulation | 1 | 2021 | 251 | 0.180 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 25043 | 0.180 |
Why?
|
Photochemotherapy | 1 | 2006 | 807 | 0.170 |
Why?
|
HIV-1 | 2 | 2019 | 6939 | 0.170 |
Why?
|
Fibrin | 1 | 2021 | 506 | 0.170 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15540 | 0.170 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4838 | 0.170 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 2872 | 0.170 |
Why?
|
Crime | 1 | 2020 | 215 | 0.170 |
Why?
|
Long QT Syndrome | 1 | 2023 | 453 | 0.170 |
Why?
|
Piperazines | 2 | 2007 | 2488 | 0.160 |
Why?
|
Hematopoietic System | 1 | 2018 | 109 | 0.160 |
Why?
|
Acetaldehyde | 1 | 2018 | 39 | 0.160 |
Why?
|
Folic Acid | 1 | 2005 | 1300 | 0.160 |
Why?
|
Noise | 1 | 2020 | 279 | 0.160 |
Why?
|
Endothelium, Vascular | 3 | 2021 | 4456 | 0.160 |
Why?
|
Prediabetic State | 1 | 2023 | 499 | 0.160 |
Why?
|
Malondialdehyde | 1 | 2018 | 105 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12245 | 0.160 |
Why?
|
Purines | 4 | 2023 | 594 | 0.160 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 935 | 0.150 |
Why?
|
Electrons | 1 | 2019 | 268 | 0.150 |
Why?
|
Incidence | 5 | 2018 | 20947 | 0.150 |
Why?
|
Homocystine | 1 | 1997 | 22 | 0.150 |
Why?
|
Epoxide Hydrolases | 1 | 2018 | 122 | 0.150 |
Why?
|
Causality | 1 | 2023 | 1275 | 0.150 |
Why?
|
Hypercholesterolemia | 2 | 2016 | 1151 | 0.150 |
Why?
|
Chronic Disease | 3 | 2020 | 9146 | 0.140 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5034 | 0.140 |
Why?
|
Diagnostic Imaging | 3 | 2017 | 3507 | 0.140 |
Why?
|
Myocardial Contraction | 2 | 2007 | 1585 | 0.140 |
Why?
|
Endothelium | 1 | 2019 | 778 | 0.140 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 581 | 0.140 |
Why?
|
Tomography, Emission-Computed | 4 | 2003 | 1144 | 0.140 |
Why?
|
Permeability | 1 | 2018 | 738 | 0.130 |
Why?
|
Esters | 5 | 2016 | 210 | 0.130 |
Why?
|
Follow-Up Studies | 9 | 2019 | 39050 | 0.130 |
Why?
|
Brain | 3 | 2023 | 26385 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 791 | 0.130 |
Why?
|
Cicatrix | 1 | 2021 | 764 | 0.130 |
Why?
|
Cathepsins | 1 | 2016 | 241 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5078 | 0.130 |
Why?
|
Cell Death | 1 | 2020 | 1706 | 0.130 |
Why?
|
Interleukin-6 | 2 | 2023 | 3200 | 0.130 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2015 | 94 | 0.130 |
Why?
|
Systems Integration | 1 | 2017 | 440 | 0.130 |
Why?
|
Radiographic Image Enhancement | 2 | 2010 | 885 | 0.120 |
Why?
|
Rhamnose | 1 | 2014 | 18 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2001 | 851 | 0.120 |
Why?
|
Multicenter Studies as Topic | 2 | 2023 | 1677 | 0.120 |
Why?
|
Asthma | 1 | 2013 | 6011 | 0.120 |
Why?
|
Sulfones | 2 | 2007 | 437 | 0.120 |
Why?
|
Troponin T | 2 | 2023 | 754 | 0.120 |
Why?
|
Clavicle | 1 | 2016 | 209 | 0.120 |
Why?
|
Amides | 5 | 2016 | 459 | 0.120 |
Why?
|
Hydroxyurea | 1 | 2015 | 290 | 0.120 |
Why?
|
Homocysteine | 1 | 1997 | 647 | 0.120 |
Why?
|
Brain Diseases | 1 | 2022 | 1563 | 0.110 |
Why?
|
Anticholesteremic Agents | 4 | 2016 | 979 | 0.110 |
Why?
|
Pyrazoles | 1 | 2023 | 1972 | 0.110 |
Why?
|
Hypolipidemic Agents | 2 | 2014 | 604 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1339 | 0.110 |
Why?
|
Apolipoprotein A-I | 1 | 2014 | 281 | 0.110 |
Why?
|
Prevalence | 3 | 2020 | 15226 | 0.110 |
Why?
|
California | 1 | 2017 | 1402 | 0.110 |
Why?
|
Thoracic Arteries | 1 | 2012 | 41 | 0.110 |
Why?
|
Drugs, Investigational | 1 | 2014 | 214 | 0.110 |
Why?
|
Disease Models, Animal | 8 | 2021 | 18029 | 0.110 |
Why?
|
Cell Hypoxia | 1 | 2015 | 675 | 0.110 |
Why?
|
Cohort Studies | 6 | 2022 | 40561 | 0.100 |
Why?
|
Particle Size | 1 | 2016 | 1642 | 0.100 |
Why?
|
Cholesterol, LDL | 4 | 2015 | 2356 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2023 | 1107 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 973 | 0.100 |
Why?
|
Iopamidol | 1 | 2011 | 191 | 0.100 |
Why?
|
Ultrasonography, Interventional | 2 | 2016 | 1486 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2023 | 3279 | 0.100 |
Why?
|
Epitopes | 1 | 2018 | 2571 | 0.100 |
Why?
|
Cyclopropanes | 1 | 2012 | 416 | 0.100 |
Why?
|
Viral Load | 2 | 2017 | 3299 | 0.100 |
Why?
|
Alcohol Drinking | 1 | 2023 | 3966 | 0.090 |
Why?
|
Cell Membrane | 1 | 2020 | 3748 | 0.090 |
Why?
|
Organ Specificity | 2 | 2006 | 2008 | 0.090 |
Why?
|
Stroke Volume | 2 | 2018 | 5007 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1997 | 1504 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1186 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
Iron | 1 | 2018 | 1774 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2019 | 1873 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10943 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3508 | 0.090 |
Why?
|
United States | 7 | 2021 | 69872 | 0.090 |
Why?
|
Cross-Over Studies | 3 | 2005 | 2029 | 0.090 |
Why?
|
Quality of Life | 4 | 2022 | 12804 | 0.090 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2014 | 373 | 0.090 |
Why?
|
Odds Ratio | 4 | 2014 | 9849 | 0.090 |
Why?
|
Monocytes | 3 | 2018 | 2596 | 0.090 |
Why?
|
Hospitals, General | 1 | 2013 | 749 | 0.090 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2734 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7913 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1616 | 0.080 |
Why?
|
Amino Acids | 1 | 2015 | 1736 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4420 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2924 | 0.080 |
Why?
|
Pilot Projects | 2 | 2018 | 8324 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.080 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 850 | 0.080 |
Why?
|
Age Distribution | 2 | 2011 | 2902 | 0.080 |
Why?
|
Blood Pressure | 5 | 2007 | 8554 | 0.070 |
Why?
|
Exercise Test | 2 | 2012 | 2074 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
Blood Flow Velocity | 2 | 2015 | 1423 | 0.070 |
Why?
|
Recurrence | 2 | 2016 | 8340 | 0.070 |
Why?
|
Mice | 8 | 2021 | 81183 | 0.070 |
Why?
|
Linear Models | 2 | 2014 | 5952 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3086 | 0.070 |
Why?
|
Dinucleoside Phosphates | 1 | 2006 | 74 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.070 |
Why?
|
Friedreich Ataxia | 1 | 2007 | 76 | 0.070 |
Why?
|
Chlorophyllides | 1 | 2006 | 53 | 0.070 |
Why?
|
Tomography, Spiral Computed | 1 | 2008 | 280 | 0.070 |
Why?
|
Reference Values | 3 | 2011 | 4982 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4149 | 0.070 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 380 | 0.070 |
Why?
|
Sex Distribution | 1 | 2011 | 2297 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2017 | 2958 | 0.070 |
Why?
|
Hemodynamics | 3 | 2015 | 4199 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11366 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2107 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2011 | 834 | 0.060 |
Why?
|
Heart Failure | 3 | 2023 | 10900 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2010 | 1641 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3610 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1671 | 0.060 |
Why?
|
Canada | 2 | 2023 | 2065 | 0.060 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1715 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7322 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9727 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1125 | 0.060 |
Why?
|
Nitroprusside | 1 | 2004 | 275 | 0.060 |
Why?
|
Logistic Models | 3 | 2013 | 13408 | 0.060 |
Why?
|
Plethysmography | 1 | 2004 | 180 | 0.060 |
Why?
|
Infusions, Intra-Arterial | 1 | 2004 | 234 | 0.060 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 255 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Verapamil | 1 | 2004 | 244 | 0.060 |
Why?
|
Graft Rejection | 1 | 2016 | 4397 | 0.060 |
Why?
|
Algorithms | 2 | 2016 | 13881 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3386 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2024 | 164 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 9959 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1912 | 0.050 |
Why?
|
Catecholamines | 1 | 2003 | 387 | 0.050 |
Why?
|
Nuclear Medicine | 1 | 2005 | 233 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2014 | 6365 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2303 | 0.050 |
Why?
|
Myocardial Reperfusion | 1 | 2003 | 351 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2011 | 1422 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1970 | 0.050 |
Why?
|
Mitochondria, Heart | 1 | 2003 | 247 | 0.050 |
Why?
|
Forearm | 1 | 2004 | 409 | 0.050 |
Why?
|
Vena Cava, Superior | 1 | 2022 | 193 | 0.050 |
Why?
|
Brain Infarction | 1 | 2023 | 299 | 0.050 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 178 | 0.050 |
Why?
|
Myocardial Stunning | 1 | 2001 | 68 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 916 | 0.050 |
Why?
|
Drug Combinations | 1 | 2006 | 1959 | 0.050 |
Why?
|
Dobutamine | 1 | 2000 | 123 | 0.050 |
Why?
|
Pyridines | 1 | 2012 | 2825 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4256 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 690 | 0.050 |
Why?
|
Myocardial Infarction | 2 | 2012 | 11727 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 2073 | 0.050 |
Why?
|
Lipoproteins | 2 | 2016 | 878 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2007 | 1869 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2009 | 1912 | 0.050 |
Why?
|
Scotland | 1 | 2020 | 155 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1917 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2016 | 19229 | 0.050 |
Why?
|
Methionine | 1 | 2002 | 590 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2015 | 10481 | 0.040 |
Why?
|
Thyrotropin | 1 | 2003 | 849 | 0.040 |
Why?
|
Troponin | 2 | 2014 | 524 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21827 | 0.040 |
Why?
|
Heart Rate | 3 | 2007 | 4091 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1460 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.040 |
Why?
|
England | 1 | 2020 | 522 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 617 | 0.040 |
Why?
|
Young Adult | 5 | 2016 | 56430 | 0.040 |
Why?
|
Electrocardiography | 3 | 2012 | 6442 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12720 | 0.040 |
Why?
|
Rest | 1 | 2003 | 901 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 591 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2000 | 535 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2014 | 2971 | 0.040 |
Why?
|
Syndrome | 1 | 2003 | 3251 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1537 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2018 | 426 | 0.040 |
Why?
|
Survival Rate | 1 | 2011 | 12788 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10388 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12745 | 0.030 |
Why?
|
Apolipoproteins E | 2 | 2015 | 1438 | 0.030 |
Why?
|
Nitroglycerin | 1 | 1997 | 325 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 551 | 0.030 |
Why?
|
Dideoxynucleosides | 1 | 2015 | 122 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 2015 | 231 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2007 | 1912 | 0.030 |
Why?
|
Blood Glucose | 2 | 2013 | 6256 | 0.030 |
Why?
|
Ultrasonography | 2 | 2014 | 5985 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2219 | 0.030 |
Why?
|
Venae Cavae | 1 | 2013 | 41 | 0.030 |
Why?
|
Progesterone | 1 | 1998 | 776 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2014 | 100 | 0.030 |
Why?
|
Ligation | 1 | 2014 | 453 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2014 | 2866 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1580 | 0.030 |
Why?
|
Autoradiography | 1 | 2014 | 745 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3798 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2013 | 235 | 0.030 |
Why?
|
Adolescent | 3 | 2016 | 85781 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
Sulfonamides | 1 | 2021 | 1938 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 638 | 0.030 |
Why?
|
Cold Temperature | 1 | 2015 | 772 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 1998 | 1203 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14557 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 2020 | 0.020 |
Why?
|
Exercise | 1 | 2007 | 5615 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 294 | 0.020 |
Why?
|
Endarterectomy | 1 | 2011 | 195 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 354 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2014 | 588 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 611 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 472 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 2942 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2012 | 558 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2274 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 391 | 0.020 |
Why?
|
Neutropenia | 1 | 2014 | 895 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7659 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11031 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 638 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1590 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2001 | 3670 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1997 | 2132 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7279 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1593 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4161 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6459 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3340 | 0.020 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2007 | 101 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 770 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2007 | 264 | 0.020 |
Why?
|
Endarterectomy, Carotid | 1 | 2011 | 546 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2007 | 411 | 0.020 |
Why?
|
Swine | 1 | 2016 | 5917 | 0.020 |
Why?
|
Systole | 1 | 2007 | 958 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 686 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2007 | 936 | 0.020 |
Why?
|
Body Size | 1 | 2007 | 461 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2657 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4933 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10397 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2505 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7149 | 0.010 |
Why?
|
Molecular Structure | 1 | 2006 | 1899 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2252 | 0.010 |
Why?
|
Antigens, CD | 1 | 2012 | 4026 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1904 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8664 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8480 | 0.010 |
Why?
|
Motor Activity | 1 | 2007 | 2714 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12959 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10252 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2007 | 3821 | 0.010 |
Why?
|
Rats | 1 | 2006 | 24260 | 0.010 |
Why?
|
Postmenopause | 1 | 1998 | 2461 | 0.010 |
Why?
|